Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3376
Silvercrest Asset Management
SAMG
$80M
| $188K | ﹤0.01% |
18,566
-21
| -0.1% | -$256 |
2022 Q2
16 quarters
|
|
3377
Armata Pharmaceuticals
ARMP
$135M
| $187K | ﹤0.01% |
+28,857
| New | +$265K |
2026 Q2
0 quarters
|
|
3378
Brand Engagement Network
BNAI
$39.6M
| $187K | ﹤0.01% |
+10,903
| New | +$284K |
2026 Q2
0 quarters
|
|
3379
Sui Group Holdings
SUIG
$108M
| $184K | ﹤0.01% |
158,221
-2,570
| -2% | -$3.7K |
2025 Q3
3 quarters
|
|
3380
CVRx
CVRX
$42.1M
| $182K | ﹤0.01% |
35,398
-5,423
| -13% | -$35K |
2023 Q2
12 quarters
|
|
3381
Ethos Technologies Inc
LIFE
$2.36B
| $181K | ﹤0.01% |
10,000
| – | – |
2026 Q1
1 quarter
|
|
3382
Carlsmed
CARL
$394M
| $179K | ﹤0.01% |
17,276
+501
| +3% | +$5.27K |
2025 Q3
3 quarters
|
|
3383
Alpha Teknova
TKNO
$475M
| $174K | ﹤0.01% |
30,703
+14,956
| +95% | +$59.4K |
2025 Q2
4 quarters
|
|
3384
Playboy Inc
PLBY
$118M
| $174K | ﹤0.01% |
+142,322
| New | +$216K |
2026 Q2
0 quarters
|
|
3385
Definitive Healthcare
DH
$105M
| $168K | ﹤0.01% |
201,901
-47,749
| -19% | -$43.7K |
2021 Q4
18 quarters
|
|
3386
Gossamer Bio
GOSS
$56.9M
| $163K | ﹤0.01% |
12,407
-6,469
| -34% | -$144K |
2019 Q1
29 quarters
|
|
3387
Roadzen
RDZN
$96.2M
| $163K | ﹤0.01% |
+111,896
| New | +$178K |
2026 Q2
0 quarters
|
|
3388
ZenaTech Inc
ZENA
$98.7M
| $161K | ﹤0.01% |
+107,431
| New | +$192K |
2026 Q2
0 quarters
|
|
3389
Tron Inc
TRON
$593M
| $159K | ﹤0.01% |
+98,995
| New | +$200K |
2026 Q2
0 quarters
|
|
3390
DELISTED
GETTY IMAGES HLDGS INC A
GETY
| $159K | ﹤0.01% |
185,318
-175,825
| -49% | -$152K |
2022 Q3
15 quarters
|
|
3391
Smith Douglas Homes
SDHC
$85.2M
| $156K | ﹤0.01% |
+10,061
| New | +$134K |
2026 Q2
0 quarters
|
|
3392
NLI Holdings
NL
$339M
| $151K | ﹤0.01% |
25,335
+87
| +0.3% | +$534 |
2013 Q2
52 quarters
|
|
3393
First Guaranty Bancshares
FGBI
$138M
| $147K | ﹤0.01% |
+14,620
| New | +$141K |
2026 Q2
0 quarters
|
|
3394
Presidio Production Co
FTW
$293M
| $146K | ﹤0.01% |
+12,000
| New | +$137K |
2026 Q2
0 quarters
|
|
3395
Forafric Global
AFRI
$343M
| $145K | ﹤0.01% |
14,401
| – | – |
2025 Q4
2 quarters
|
|
3396
Lee Enterprises
LEE
$170M
| $145K | ﹤0.01% |
+16,173
| New | +$146K |
2026 Q2
0 quarters
|
|
3397
Mercer International
MERC
$16M
| $145K | ﹤0.01% |
218,958
-30,288
| -12% | -$30.1K |
2013 Q2
52 quarters
|
|
3398
SBC Medical Group
SBC
$557M
| $144K | ﹤0.01% |
46,855
+28,654
| +157% | +$97.2K |
2025 Q2
4 quarters
|
|
3399
MaxCyte
MXCT
$104M
| $144K | ﹤0.01% |
117,192
-211,459
| -64% | -$211K |
2021 Q3
19 quarters
|
|
3400
TOYO Co
TOYO
$187M
| $138K | ﹤0.01% |
+19,800
| New | +$243K |
2026 Q2
0 quarters
|
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.